BioMarin Pharmaceutical (BMRN) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO, who welcomed participants and outlined the virtual format and rules of conduct.

• The Secretary confirmed the availability of the stockholder list and notice of meeting, and the Inspector of Election was appointed.

• A quorum was established with 90.96% of shares represented, allowing business to proceed.

Board and executive committee updates

• Ten directors were nominated for election to serve until the next annual meeting or until successors are elected.

Shareholder proposals

• Four proposals were presented: election of directors, ratification of KPMG LLP as auditor, advisory vote on executive compensation, and approval of an amendment to the 2017 Equity Incentive Plan.